Anti-inflammatory Mechanism of Geniposide: Inhibiting the Hyperpermeability of Fibroblast-Like Synoviocytes via the RhoA/p38MAPK/NF-κB/F-Actin Signal Pathway
Geniposide (GE) is the extraction and purification of iridoid glycosides from the , which is a promising anti-inflammatory drug, but its mechanism of actions on rheumatoid arthritis (RA) has not been clarified. This study investigated the molecular mechanism behind GE reduced the high permeability o...
Saved in:
Published in | Frontiers in pharmacology Vol. 9; p. 105 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
15.02.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Geniposide (GE) is the extraction and purification of iridoid glycosides from the
, which is a promising anti-inflammatory drug, but its mechanism of actions on rheumatoid arthritis (RA) has not been clarified. This study investigated the molecular mechanism behind GE reduced the high permeability of fibroblast-like synoviocytes (FLSs) derived from SD rats with adjuvant arthritis (AA), with the aims of observing the action of GE in AA rats and exploring new therapeutic strategies for RA treatment. The CCK-8 method was used to detect FLSs proliferation. The pro-inflammatory cytokines levels and anti-inflammatory cytokines levels in FLSs were determined by ELISA kits. FLSs permeability assay was performed on Transwell. Immunofluorescence was used to assay the arrangement and morphology of F-actin. The expression of the key molecules related to FLSs permeability (RhoA, p-p38MAPK, NF-κB p-p65 and F-actin) was detected by western blotting. After treatment with lipopolysaccharide (LPS), the proliferation and the permeability of the cells increased significantly (all
< 0.05). The expression of RhoA, p-p38MAPK, NF-κB p-p65 and F-actin in FLSs was higher compared with the control group, and F-actin was redistributed, with the formation of additional stress fibers. But, these conditions were moderated after treatment with GE. We demonstrated that the treatment of different concentrations of GE (25, 50, and 100 μg/mL) had a significant inhibitory effect on the proliferation and permeability of FLSs
. Furthermore, the levels of interleukin (IL)-1β and IL-17 secreted by FLSs were decreased in different doses of GE groups, and the levels of anti-inflammatory cytokines (IL-4, TGF-β1) were increased. Under treatment with GE, low expression of RhoA downregulated expression of p-p38MAPK, NF-κB p-p65, and F-actin while compared with control group, and restored the hyperpermeability of FLSs due to LPS treatment. Taken together, GE might play its anti-inflammatory and immunoregulatory effects via regulating the relative equilibrium of pro-inflammatory cytokines and anti-inflammatory cytokines. GE attenuated the hyperpermeability of FLSs. The down-regulation of the conduction of RhoA/p38MAPK/NF-κB/F-actin signal may play a critical role in the mechanisms of GE on RA. GE could be an effective therapeutic agent for the treatment of RA. |
---|---|
AbstractList | Geniposide (GE) is the extraction and purification of iridoid glycosides from the Gardenia jasminoides Ellis, which is a promising anti-inflammatory drug, but its mechanism of actions on rheumatoid arthritis (RA) has not been clarified. This study investigated the molecular mechanism behind GE reduced the high permeability of fibroblast-like synoviocytes (FLSs) derived from SD rats with adjuvant arthritis (AA), with the aims of observing the action of GE in AA rats and exploring new therapeutic strategies for RA treatment. The CCK-8 method was used to detect FLSs proliferation. The pro-inflammatory cytokines levels and anti-inflammatory cytokines levels in FLSs were determined by ELISA kits. FLSs permeability assay was performed on Transwell. Immunofluorescence was used to assay the arrangement and morphology of F-actin. The expression of the key molecules related to FLSs permeability (RhoA, p-p38MAPK, NF-κB p-p65 and F-actin) was detected by western blotting. After treatment with lipopolysaccharide (LPS), the proliferation and the permeability of the cells increased significantly (all P < 0.05). The expression of RhoA, p-p38MAPK, NF-κB p-p65 and F-actin in FLSs was higher compared with the control group, and F-actin was redistributed, with the formation of additional stress fibers. But, these conditions were moderated after treatment with GE. We demonstrated that the treatment of different concentrations of GE (25, 50, and 100 μg/mL) had a significant inhibitory effect on the proliferation and permeability of FLSs in vitro. Furthermore, the levels of interleukin (IL)-1β and IL-17 secreted by FLSs were decreased in different doses of GE groups, and the levels of anti-inflammatory cytokines (IL-4, TGF-β1) were increased. Under treatment with GE, low expression of RhoA downregulated expression of p-p38MAPK, NF-κB p-p65, and F-actin while compared with control group, and restored the hyperpermeability of FLSs due to LPS treatment. Taken together, GE might play its anti-inflammatory and immunoregulatory effects via regulating the relative equilibrium of pro-inflammatory cytokines and anti-inflammatory cytokines. GE attenuated the hyperpermeability of FLSs. The down-regulation of the conduction of RhoA/p38MAPK/NF-κB/F-actin signal may play a critical role in the mechanisms of GE on RA. GE could be an effective therapeutic agent for the treatment of RA. Geniposide (GE) is the extraction and purification of iridoid glycosides from the Gardenia jasminoides Ellis , which is a promising anti-inflammatory drug, but its mechanism of actions on rheumatoid arthritis (RA) has not been clarified. This study investigated the molecular mechanism behind GE reduced the high permeability of fibroblast-like synoviocytes (FLSs) derived from SD rats with adjuvant arthritis (AA), with the aims of observing the action of GE in AA rats and exploring new therapeutic strategies for RA treatment. The CCK-8 method was used to detect FLSs proliferation. The pro-inflammatory cytokines levels and anti-inflammatory cytokines levels in FLSs were determined by ELISA kits. FLSs permeability assay was performed on Transwell. Immunofluorescence was used to assay the arrangement and morphology of F-actin. The expression of the key molecules related to FLSs permeability (RhoA, p-p38MAPK, NF-κB p-p65 and F-actin) was detected by western blotting. After treatment with lipopolysaccharide (LPS), the proliferation and the permeability of the cells increased significantly (all P < 0.05). The expression of RhoA, p-p38MAPK, NF-κB p-p65 and F-actin in FLSs was higher compared with the control group, and F-actin was redistributed, with the formation of additional stress fibers. But, these conditions were moderated after treatment with GE. We demonstrated that the treatment of different concentrations of GE (25, 50, and 100 μg/mL) had a significant inhibitory effect on the proliferation and permeability of FLSs in vitro . Furthermore, the levels of interleukin (IL)-1β and IL-17 secreted by FLSs were decreased in different doses of GE groups, and the levels of anti-inflammatory cytokines (IL-4, TGF-β1) were increased. Under treatment with GE, low expression of RhoA downregulated expression of p-p38MAPK, NF-κB p-p65, and F-actin while compared with control group, and restored the hyperpermeability of FLSs due to LPS treatment. Taken together, GE might play its anti-inflammatory and immunoregulatory effects via regulating the relative equilibrium of pro-inflammatory cytokines and anti-inflammatory cytokines. GE attenuated the hyperpermeability of FLSs. The down-regulation of the conduction of RhoA/p38MAPK/NF-κB/F-actin signal may play a critical role in the mechanisms of GE on RA. GE could be an effective therapeutic agent for the treatment of RA. Geniposide (GE) is the extraction and purification of iridoid glycosides from the , which is a promising anti-inflammatory drug, but its mechanism of actions on rheumatoid arthritis (RA) has not been clarified. This study investigated the molecular mechanism behind GE reduced the high permeability of fibroblast-like synoviocytes (FLSs) derived from SD rats with adjuvant arthritis (AA), with the aims of observing the action of GE in AA rats and exploring new therapeutic strategies for RA treatment. The CCK-8 method was used to detect FLSs proliferation. The pro-inflammatory cytokines levels and anti-inflammatory cytokines levels in FLSs were determined by ELISA kits. FLSs permeability assay was performed on Transwell. Immunofluorescence was used to assay the arrangement and morphology of F-actin. The expression of the key molecules related to FLSs permeability (RhoA, p-p38MAPK, NF-κB p-p65 and F-actin) was detected by western blotting. After treatment with lipopolysaccharide (LPS), the proliferation and the permeability of the cells increased significantly (all < 0.05). The expression of RhoA, p-p38MAPK, NF-κB p-p65 and F-actin in FLSs was higher compared with the control group, and F-actin was redistributed, with the formation of additional stress fibers. But, these conditions were moderated after treatment with GE. We demonstrated that the treatment of different concentrations of GE (25, 50, and 100 μg/mL) had a significant inhibitory effect on the proliferation and permeability of FLSs . Furthermore, the levels of interleukin (IL)-1β and IL-17 secreted by FLSs were decreased in different doses of GE groups, and the levels of anti-inflammatory cytokines (IL-4, TGF-β1) were increased. Under treatment with GE, low expression of RhoA downregulated expression of p-p38MAPK, NF-κB p-p65, and F-actin while compared with control group, and restored the hyperpermeability of FLSs due to LPS treatment. Taken together, GE might play its anti-inflammatory and immunoregulatory effects via regulating the relative equilibrium of pro-inflammatory cytokines and anti-inflammatory cytokines. GE attenuated the hyperpermeability of FLSs. The down-regulation of the conduction of RhoA/p38MAPK/NF-κB/F-actin signal may play a critical role in the mechanisms of GE on RA. GE could be an effective therapeutic agent for the treatment of RA. |
Author | Wang, Wen-Yu Deng, Ran Dai, Li Zhang, Zheng-Rong Fu, Jun Li, Feng Wu, Hong |
AuthorAffiliation | 1 Key Laboratory of Xin’an Medicine, Ministry of Education , Hefei , China 2 College of Pharmacy, Anhui University of Chinese Medicine , Hefei , China |
AuthorAffiliation_xml | – name: 2 College of Pharmacy, Anhui University of Chinese Medicine , Hefei , China – name: 1 Key Laboratory of Xin’an Medicine, Ministry of Education , Hefei , China |
Author_xml | – sequence: 1 givenname: Ran surname: Deng fullname: Deng, Ran organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China – sequence: 2 givenname: Feng surname: Li fullname: Li, Feng organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China – sequence: 3 givenname: Hong surname: Wu fullname: Wu, Hong organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China – sequence: 4 givenname: Wen-Yu surname: Wang fullname: Wang, Wen-Yu organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China – sequence: 5 givenname: Li surname: Dai fullname: Dai, Li organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China – sequence: 6 givenname: Zheng-Rong surname: Zhang fullname: Zhang, Zheng-Rong organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China – sequence: 7 givenname: Jun surname: Fu fullname: Fu, Jun organization: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29497378$$D View this record in MEDLINE/PubMed |
BookMark | eNpVktFu0zAUhi00xEbZPVcol9ykjePYcbhAChPdKjqYGFxbjnPSeCR2sN2ivAwPwkPwTKTtmDbLkq3j___Okfy_RCfGGkDoNU7mhPBi0QytdPM0wXyeJDihz9AZZozEBcfpyaP7KTr3_i6ZFikKwrIX6DQtsiInOT9Dv0sTdKxN08m-l8G6MboG1UqjfR_ZJroEowfrdQ3vopVpdaWDNpsotBBdjQO4afcgK93pMO71S105W3XSh3itf0B0Oxq701aNAXy00_Lg_NracjEQfl3efFp8XsZ__3xYLONSTejoVm-M7KIbGdpfcnyFnjey83B-f87Q9-XHbxdX8frL5eqiXMcqY2mIQXJWV0wq2chMqXyqNjQjFPOUFwrquoGqwQwTTInKeAXAeAqkgBSTSgEjM7Q6cmsr78TgdC_dKKzU4lCwbiOkC1p1IChOCWNVmijgGaUZx01NGc2B5_X0GWpivT-yhm3VQ63ABCe7J9CnL0a3YmN3gnLMs2miGXp7D3D25xZ8EL32CrpOGrBbL6YuCWF5xukkTY5S5az3DpqHNjgR-5SIQ0r2Fi4OKZksbx6P92D4nwnyD0OfvnQ |
CitedBy_id | crossref_primary_10_1016_j_intimp_2023_109894 crossref_primary_10_3389_fphar_2022_969408 crossref_primary_10_1016_j_phymed_2022_154068 crossref_primary_10_1007_s43440_020_00068_4 crossref_primary_10_1155_2022_9312611 crossref_primary_10_1016_j_jconrel_2021_03_008 crossref_primary_10_1155_2021_8827891 crossref_primary_10_3389_fphar_2020_584176 crossref_primary_10_1016_j_jtcms_2021_06_001 crossref_primary_10_1007_s40495_019_00177_6 crossref_primary_10_1016_j_jep_2021_114067 crossref_primary_10_1002_ptr_7130 crossref_primary_10_1016_j_jep_2023_117397 crossref_primary_10_1002_ptr_7211 crossref_primary_10_1039_C9RA01448A crossref_primary_10_1016_j_intimp_2024_112082 crossref_primary_10_1016_j_bcp_2023_115973 crossref_primary_10_1039_C9RA00060G crossref_primary_10_3389_fphar_2020_569251 crossref_primary_10_1016_j_heliyon_2024_e32705 crossref_primary_10_1016_j_ejphar_2022_175271 crossref_primary_10_1016_j_intimp_2019_106121 crossref_primary_10_1016_j_intimp_2018_09_049 crossref_primary_10_1016_j_phrs_2020_104631 crossref_primary_10_1016_j_jep_2022_115629 crossref_primary_10_1155_2018_7379893 crossref_primary_10_3389_fphar_2019_00411 crossref_primary_10_1002_ptr_6509 crossref_primary_10_1016_j_jnutbio_2020_108555 crossref_primary_10_3390_molecules27103319 crossref_primary_10_1016_j_chemosphere_2018_03_162 crossref_primary_10_1021_acs_jafc_8b00739 crossref_primary_10_3389_fcell_2021_603742 crossref_primary_10_1111_1756_185X_13958 crossref_primary_10_1155_2020_5786053 crossref_primary_10_1016_j_isci_2021_103620 crossref_primary_10_1186_s13020_022_00616_5 crossref_primary_10_3390_cells9061467 crossref_primary_10_1186_s10020_022_00490_9 crossref_primary_10_3389_fphar_2019_00491 crossref_primary_10_1021_acs_jproteome_0c00300 crossref_primary_10_3390_pr9071081 crossref_primary_10_1016_j_jep_2021_113958 crossref_primary_10_1016_j_intimp_2019_105840 |
Cites_doi | 10.1016/j.intimp.2012.07.006 10.1155/2012/948218 10.1155/2017/2405291 10.1177/1535370216631028 10.1007/s12026-016-8794-x 10.1096/fj.15-279802 10.1002/cam4.1019 10.1089/ars.2013.5713 10.1002/art.38327 10.1016/j.bbrc.2016.06.152 10.3389/fphar.2017.00538 10.1016/j.cellbi.2007.01.036 10.1186/1475-2840-11-7 10.1016/j.intimp.2017.03.007 10.1002/art.1780281005 10.1055/s-0031-1298212 10.1007/s00296-012-2383-7 10.1007/s10067-013-2340-1 10.1155/2015/832916 10.1016/j.bbrc.2011.07.031 10.1016/j.molimm.2017.08.024 10.1016/j.virusres.2014.07.027 10.1016/j.coph.2013.02.006 10.1002/ptr.5775 10.1155/2016/3906108 10.18632/oncotarget.17331 10.1002/art.38141 10.3899/jrheum.141292 10.1007/s10753-017-0694-2 10.1016/j.pharep.2015.06.004 10.1002/ptr.5847 10.1093/rheumatology/keq188 10.1016/S1875-5364(15)30087-X 10.1093/rheumatology/keu487 10.1089/jir.2014.0188 10.1038/nature01661 10.1016/j.immuni.2017.02.006 10.1016/j.intimp.2014.02.021 10.2174/1381612820666140825122247 10.1155/2015/387094 10.1038/cddis.2016.490 10.1016/j.cyto.2014.12.027 10.3892/ijmm.2017.2896 10.1371/journal.pone.0170346 10.1016/j.semarthrit.2013.06.001 10.1016/j.intimp.2015.01.001 10.1038/sj.mn.7800149 10.1136/ard.2010.142240 10.1038/s41598-017-17566-w 10.1016/j.biopha.2017.02.045 10.1038/aps.2016.168 10.1016/j.jpba.2015.01.044 |
ContentType | Journal Article |
Copyright | Copyright © 2018 Deng, Li, Wu, Wang, Dai, Zhang and Fu. 2018 Deng, Li, Wu, Wang, Dai, Zhang and Fu |
Copyright_xml | – notice: Copyright © 2018 Deng, Li, Wu, Wang, Dai, Zhang and Fu. 2018 Deng, Li, Wu, Wang, Dai, Zhang and Fu |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fphar.2018.00105 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1663-9812 |
EndPage | 105 |
ExternalDocumentID | oai_doaj_org_article_512366b20ce8455481fd5657e87d201c 10_3389_fphar_2018_00105 29497378 |
Genre | Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 81073122 – fundername: National Natural Science Foundation of China grantid: 81473400 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EMOBN GROUPED_DOAJ GX1 HYE IAO IEA IHR IHW IPNFZ KQ8 M48 M~E NPM O5R O5S OK1 P2P PGMZT RIG RNS RPM AAYXX CITATION 7X8 ITC 5PM |
ID | FETCH-LOGICAL-c462t-ea86db6acafa4cc7c46f543518289ceddfebf1613153c48bee682e39e213bce63 |
IEDL.DBID | RPM |
ISSN | 1663-9812 |
IngestDate | Fri Oct 04 13:14:28 EDT 2024 Tue Sep 17 21:25:26 EDT 2024 Sat Aug 17 00:43:48 EDT 2024 Thu Sep 26 19:00:07 EDT 2024 Wed Oct 16 00:59:53 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-ea86db6acafa4cc7c46f543518289ceddfebf1613153c48bee682e39e213bce63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Wei Wei, Anhui Medical University, China Reviewed by: Youcai Deng, Third Military Medical University, China; Huichang Bi, Sun Yat-sen University, China; Yan Huang, Anhui Medical University, China These authors have contributed equally to this work and are co-first authors. This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818421/ |
PMID | 29497378 |
PQID | 2010367485 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_512366b20ce8455481fd5657e87d201c pubmedcentral_primary_oai_pubmedcentral_nih_gov_5818421 proquest_miscellaneous_2010367485 crossref_primary_10_3389_fphar_2018_00105 pubmed_primary_29497378 |
PublicationCentury | 2000 |
PublicationDate | 2018-02-15 |
PublicationDateYYYYMMDD | 2018-02-15 |
PublicationDate_xml | – month: 02 year: 2018 text: 2018-02-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in pharmacology |
PublicationTitleAlternate | Front Pharmacol |
PublicationYear | 2018 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Lubberts (B23) 2015; 21 Ni (B28) 2017; 12 Xu (B49) 2017; 38 Wang (B43) 2015; 8 Walsh (B39) 2010; 49 Xiaofeng (B48) 2012; 78 Filer (B12) 2013; 13 Firestein (B14) 2017; 46 Liu (B22) 2017; 91 Dai (B8) 2014; 20 Byng-Maddick (B1) 2015; 54 Pan (B29) 2017 Chen (B5) 2015; 108 Singer (B34) 1985; 28 Wang (B41) 2017; 31 Wang (B42) 2017; 89 Ng (B27) 2015; 35 Kawanami (B17) 2011; 411 Zhuang (B55) 2017; 8 Yin (B50) 2016; 477 Wu (B46) 2008; 14 Wei (B44) 2017; 46 See (B33) 2013; 43 Dasgupta (B9) 2017; 6 Zou (B56) 2016; 68 Dong (B11) 2017; 8 Tan (B38) 2017; 2017 Dong (B10) 2015; 2015 Li (B21) 2013; 32 Kim (B18) 2017; 8 Suzuki (B36) 2015; 42 Ganesan (B16) 2016; 64 Zhang (B54) 2017; 31 Wang (B40) 2012; 11 Poli (B30) 2002; 9 Criado (B7) 2014; 66 Firestein (B13) 2003; 423 Chakera (B2) 2012; 2012 Wei (B45) 1986; 2 Yu (B52) 2016; 241 Monickaraj (B26) 2016; 30 Puthenedam (B31) 2007; 31 Connolly (B6) 2011; 70 Kong (B19) 2016; 2016 Mankia (B25) 2015; 20 Qian (B32) 2017; 7 Xiao (B47) 2013; 33 Fu (B15) 2012; 14 Zhang (B53) 2014; 192 Lv (B24) 2015; 13 Chang (B3) 2015; 24 Chen (B4) 2015; 2015 Yokota (B51) 2017; 39 Krabben (B20) 2013; 65 Stanley (B35) 2014; 20 Talaat (B37) 2015; 72 |
References_xml | – volume: 14 start-page: 792 year: 2012 ident: B15 article-title: Geniposide, from Gardenia jasminoides Ellis, inhibits the inflammatory response in the primary mouse macrophages and mouse models. publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2012.07.006 contributor: fullname: Fu – volume: 2012 year: 2012 ident: B2 article-title: The phenotype of circulating follicular-helper T cells in patients with rheumatoid arthritis defines CD200 as a potential therapeutic target. publication-title: Clin. Dev. Immunol. doi: 10.1155/2012/948218 contributor: fullname: Chakera – volume: 2017 year: 2017 ident: B38 article-title: Cytokine imbalance as a common mechanism in both psoriasis and rheumatoid arthritis. publication-title: Mdiators Inflamm. doi: 10.1155/2017/2405291 contributor: fullname: Tan – volume: 241 start-page: 800 year: 2016 ident: B52 article-title: Berberine induces dedifferentiation by actin cytoskeleton reorganization via phosphoinositide 3-kinase/Akt and p38 kinase pathways in rabbit articular chondrocytes. publication-title: Exp. Biol. Med. doi: 10.1177/1535370216631028 contributor: fullname: Yu – volume: 20 start-page: 129 year: 2015 ident: B25 article-title: Is localized autoimmunity the trigger for rheumatoid arthritis unravelling new targets for prevention. publication-title: Discov. Med. contributor: fullname: Mankia – volume: 64 start-page: 1071 year: 2016 ident: B16 article-title: Majoon ushba, a polyherbal compound, suppresses pro-inflammatory mediators and RANKL expression via modulating NFκB and MAPKs signaling pathways in fibroblast-like synoviocytes from adjuvant-induced arthritic rats. publication-title: Immunol. Res. doi: 10.1007/s12026-016-8794-x contributor: fullname: Ganesan – volume: 30 start-page: 1670 year: 2016 ident: B26 article-title: Cathepsin D: an Mϕ-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy. publication-title: FASEB J. doi: 10.1096/fj.15-279802 contributor: fullname: Monickaraj – volume: 6 start-page: 809 year: 2017 ident: B9 article-title: Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathway. publication-title: Cancer Med. doi: 10.1002/cam4.1019 contributor: fullname: Dasgupta – volume: 20 start-page: 2026 year: 2014 ident: B35 article-title: NADPH oxidase complex-derived reactive oxygen species, the actin cytoskeleton, and Rho GTPases in cell migration. publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2013.5713 contributor: fullname: Stanley – volume: 66 start-page: 1208 year: 2014 ident: B7 article-title: Alternative p38 MAPKs are essential for collagen-induced arthritis. publication-title: Arthritis Rheumatol. doi: 10.1002/art.38327 contributor: fullname: Criado – volume: 477 start-page: 881 year: 2016 ident: B50 article-title: Sinomenine alleviates high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the activation of RhoA/ROCK signaling pathway. publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2016.06.152 contributor: fullname: Yin – volume: 8 year: 2017 ident: B55 article-title: Tamarixinin A alleviates joint destruction of rheumatoid arthritis by blockade of MAPK, and NF-kB activation. publication-title: Front. Pharmacol. doi: 10.3389/fphar.2017.00538 contributor: fullname: Zhuang – volume: 31 start-page: 836 year: 2007 ident: B31 article-title: Modulation of tight junction barrier function by outer membrane proteins of enteropathogenic Escherichia coli: role of F-actin and junctional adhesion molecule-1. publication-title: Cell Biol. Int. doi: 10.1016/j.cellbi.2007.01.036 contributor: fullname: Puthenedam – volume: 11 year: 2012 ident: B40 article-title: RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response. publication-title: Cardiovasc. Diabetol. doi: 10.1186/1475-2840-11-7 contributor: fullname: Wang – volume: 46 start-page: 220 year: 2017 ident: B44 article-title: Anti-inflammatory mechanism of ulinastatin: inhibiting the hyperpermeability of vascular endothelial cells induced by TNF-α via the RhoA/ROCK signal pathway. publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2017.03.007 contributor: fullname: Wei – volume: 28 start-page: 1105 year: 1985 ident: B34 article-title: Extracellular matrix-cytoskeletal interactions in rheumatoid arthritis. I. Immunoelectron microscopic analysis of the fibronexus at the adhesive surface of normal porcine type B synoviocytes in vitro. publication-title: Arthritis Rheum. doi: 10.1002/art.1780281005 contributor: fullname: Singer – volume: 78 start-page: 557 year: 2012 ident: B48 article-title: Geniposide, an iridoid glucoside derived from Gardenia jasminoides, protects against lipopolysaccharide-induced acute lung injury in mice. publication-title: Planta Med. doi: 10.1055/s-0031-1298212 contributor: fullname: Xiaofeng – volume: 33 start-page: 389 year: 2013 ident: B47 article-title: Inhibitory effects of simvastatin on migration and invasion of rheumatoid fibroblast-like synoviocytes by preventing geranylgeranylation of RhoA. publication-title: Rheumatol. Int. doi: 10.1007/s00296-012-2383-7 contributor: fullname: Xiao – volume: 32 start-page: 1697 year: 2013 ident: B21 article-title: A meta-analysis of the role of p38 mitogen-activated protein kinase inhibitors in patients with active rheumatoid arthritis. publication-title: Clin. Rheumatol. doi: 10.1007/s10067-013-2340-1 contributor: fullname: Li – volume: 2015 year: 2015 ident: B10 article-title: Effect of leflunomide on the abnormal expression of lipid rafts and F-Actin in B lymphocytes from patients with systemic lupus erythematosus. publication-title: J. Immunol. Res. doi: 10.1155/2015/832916 contributor: fullname: Dong – volume: 411 start-page: 798 year: 2011 ident: B17 article-title: Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-κB signaling pathway activation in vascular endothelial cells. publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2011.07.031 contributor: fullname: Kawanami – volume: 91 start-page: 24 year: 2017 ident: B22 article-title: NLRC5 promotes cell proliferation via regulating the NF-κB signaling pathway in Rheumatoid arthritis. publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2017.08.024 contributor: fullname: Liu – volume: 192 start-page: 6 year: 2014 ident: B53 article-title: p38MAPK, Rho/ROCK and PKC pathways are involved in influenza-induced cytoskeletal rearrangement and hyperpermeability in PMVEC via phosphorylating ERM. publication-title: Virus Res. doi: 10.1016/j.virusres.2014.07.027 contributor: fullname: Zhang – volume: 13 start-page: 413 year: 2013 ident: B12 article-title: The fibroblast as a therapeutic target in rheumatoid arthritis. publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2013.02.006 contributor: fullname: Filer – volume: 31 start-page: 631 year: 2017 ident: B41 article-title: Antiinflammation effects and mechanisms study of geniposide on rats with collagen induced arthritis. publication-title: Phytother. Res. doi: 10.1002/ptr.5775 contributor: fullname: Wang – volume: 2016 year: 2016 ident: B19 article-title: Anti-inflammatory effects of TRAF-interacting protein in rheumatoid arthritis fibroblast-like synoviocytes. publication-title: Mediators Inflamm. doi: 10.1155/2016/3906108 contributor: fullname: Kong – volume: 8 start-page: 50958 year: 2017 ident: B11 article-title: EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho/ROCK signaling pathway. publication-title: Oncotarget doi: 10.18632/oncotarget.17331 contributor: fullname: Dong – volume: 65 start-page: 3051 year: 2013 ident: B20 article-title: Genetic variants in the IL-4 and IL-4 receptor genes in association with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts. publication-title: Arthritis Rheum. doi: 10.1002/art.38141 contributor: fullname: Krabben – volume: 42 start-page: 943 year: 2015 ident: B36 article-title: Upregulation of thrombospondin 1 expression in synovial tissues and plasma of rheumatoid arthritis: role of transforming growth factor-β1 toward fibroblast-like synovial cells. publication-title: J. Rheumatol. doi: 10.3899/jrheum.141292 contributor: fullname: Suzuki – volume: 8 start-page: 14562 year: 2015 ident: B43 article-title: MiR-451 inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion in rheumatoid arthritis through mediating p38MAPK signaling pathway. publication-title: Int. J. Clin. Exp. Pathol. contributor: fullname: Wang – year: 2017 ident: B29 article-title: Geniposide suppresses interleukin-1β-induced inflammation and apoptosis in rat chondrocytes via the PI3K/Akt/NF-κB signaling pathway. publication-title: Inflammation doi: 10.1007/s10753-017-0694-2 contributor: fullname: Pan – volume: 68 start-page: 7 year: 2016 ident: B56 article-title: β-Elemene induces apoptosis of human rheumatoid arthritis fibroblast-like synoviocytes via reactive oxygen species-dependent activation of p38 mitogen-activated protein kinase. publication-title: Pharmacol. Rep. doi: 10.1016/j.pharep.2015.06.004 contributor: fullname: Zou – volume: 31 start-page: 1249 year: 2017 ident: B54 article-title: Immune tolerance effect in mesenteric lymph node lymphocytes of geniposide on adjuvant arthritis rats. publication-title: Phytother. Res. doi: 10.1002/ptr.5847 contributor: fullname: Zhang – volume: 49 start-page: 1852 year: 2010 ident: B39 article-title: Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. publication-title: Rheumatology doi: 10.1093/rheumatology/keq188 contributor: fullname: Walsh – volume: 13 start-page: 831 year: 2015 ident: B24 article-title: Tetrandrine inhibits migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes through down-regulating the expressions of Rac1, Cdc42, and RhoA GTPases and activation of the PI3K/Akt and JNK signaling pathways. publication-title: Chin. J. Nat. Med. doi: 10.1016/S1875-5364(15)30087-X contributor: fullname: Lv – volume: 54 start-page: 768 year: 2015 ident: B1 article-title: The impact of biological therapy on regulatory T cells in rheumatoid arthritis. publication-title: Rheumatology doi: 10.1093/rheumatology/keu487 contributor: fullname: Byng-Maddick – volume: 14 start-page: 49 year: 2008 ident: B46 article-title: Effects and mechanisms of treating adjuvant arthritis by total glucosides of cape jasmine in rat. publication-title: Chin. J. Exp. Tradit. Med. Formul. contributor: fullname: Wu – volume: 35 start-page: 513 year: 2015 ident: B27 article-title: Interferon-gamma increases endothelial permeability by causing activation of p38 MAP kinase and actin cytoskeleton alteration. publication-title: J. Interferon Cytokine Res. doi: 10.1089/jir.2014.0188 contributor: fullname: Ng – volume: 423 start-page: 356 year: 2003 ident: B13 article-title: Evolving concepts of rheumatoid arthritis. publication-title: Nature doi: 10.1038/nature01661 contributor: fullname: Firestein – volume: 46 start-page: 183 year: 2017 ident: B14 article-title: Immunopathogenesis of rheumatoid arthritis. publication-title: Immunity doi: 10.1016/j.immuni.2017.02.006 contributor: fullname: Firestein – volume: 20 start-page: 46 year: 2014 ident: B8 article-title: Effects and mechanisms of geniposide on rats with adjuvant arthritis. publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2014.02.021 contributor: fullname: Dai – volume: 21 start-page: 142 year: 2015 ident: B23 article-title: Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatment. publication-title: Curr. Pharm. Des. doi: 10.2174/1381612820666140825122247 contributor: fullname: Lubberts – volume: 2015 year: 2015 ident: B4 article-title: Suppression of inflammation and arthritis by orally administrated cardiotoxin from Naja naja atra. publication-title: Evid. Based Complement. Alternat. Med. doi: 10.1155/2015/387094 contributor: fullname: Chen – volume: 8 year: 2017 ident: B18 article-title: IL-17-mediated mitochondrial dysfunction impairs apoptosis in rheumatoid arthritis synovial fibroblasts through activation of autophagy. publication-title: Cell Death Dis. doi: 10.1038/cddis.2016.490 contributor: fullname: Kim – volume: 72 start-page: 146 year: 2015 ident: B37 article-title: Th1/Th2/Th17/Treg cytokinein systemic lupus erythematosus (SLE) patients: correlation with disease activity. publication-title: Cytokine doi: 10.1016/j.cyto.2014.12.027 contributor: fullname: Talaat – volume: 2 start-page: 29 year: 1986 ident: B45 article-title: Pharmacological effects of isoxicam. publication-title: Chin. Pharmacol. Bull. contributor: fullname: Wei – volume: 39 start-page: 799 year: 2017 ident: B51 article-title: ROCK/actin/MRTF signaling promotes the fibrogenic phenotype of fibroblast-like synoviocytes derived from the temporomandibular joint. publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2017.2896 contributor: fullname: Yokota – volume: 12 year: 2017 ident: B28 article-title: TNFα alters occludin and cerebral endothelial permeability: role of p38MAPK. publication-title: PLOS ONE doi: 10.1371/journal.pone.0170346 contributor: fullname: Ni – volume: 43 start-page: 381 year: 2013 ident: B33 article-title: Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. publication-title: Semin. Arthritis Rheum. doi: 10.1016/j.semarthrit.2013.06.001 contributor: fullname: See – volume: 24 start-page: 451 year: 2015 ident: B3 article-title: Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis. publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2015.01.001 contributor: fullname: Chang – volume: 9 start-page: 419 year: 2002 ident: B30 article-title: Contribution of F-Actin to barrier properties of the blood-joint pathway. publication-title: Microcirculation doi: 10.1038/sj.mn.7800149 contributor: fullname: Poli – volume: 70 start-page: 1296 year: 2011 ident: B6 article-title: Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis. publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.2010.142240 contributor: fullname: Connolly – volume: 7 year: 2017 ident: B32 article-title: Effect of qianghuo erhuang decoction on T regulatory and T helper 17 cells in treatment of adjuvant-induced arthritis in rats. publication-title: Sci. Rep. doi: 10.1038/s41598-017-17566-w contributor: fullname: Qian – volume: 89 start-page: 426 year: 2017 ident: B42 article-title: A recombinant IgG-like bispecific antibody acting as interleukin-1β and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritis. publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2017.02.045 contributor: fullname: Wang – volume: 38 start-page: 688 year: 2017 ident: B49 article-title: Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function. publication-title: Acta Pharmacol. Sin. doi: 10.1038/aps.2016.168 contributor: fullname: Xu – volume: 108 start-page: 122 year: 2015 ident: B5 article-title: Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies. publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2015.01.044 contributor: fullname: Chen |
SSID | ssj0000399364 |
Score | 2.4207666 |
Snippet | Geniposide (GE) is the extraction and purification of iridoid glycosides from the
, which is a promising anti-inflammatory drug, but its mechanism of actions... Geniposide (GE) is the extraction and purification of iridoid glycosides from the Gardenia jasminoides Ellis , which is a promising anti-inflammatory drug, but... Geniposide (GE) is the extraction and purification of iridoid glycosides from the Gardenia jasminoides Ellis, which is a promising anti-inflammatory drug, but... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 105 |
SubjectTerms | Pharmacology |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQT1wQlL8FioyEKiE1Ckkcx8stRYTlZ6sVbaXeItsZsxHaZNVNi_IyPAgPwTMx42zbXYTEBSmnxJEdz3jmm8z4M2MvM1VJKSITKOcUkWrjkoohDrQifqVEJxLof8f0SE5Oxcez9GzjqC-qCRvogYeJC1OiB5Emfm1BCfR9KnIVpepAZRU6L-utb5RuBFPeBpPflWLIS2IUNg7dcq6J_zOi2smITqvb8EOerv9vGPPPUskN31PcZXfWoJHnw2DvsVvQ7LL92cA63R_wk5tNVKsDvs9nN3zU_X32I2-6OkBNQuEvfFKdT4E2_NarBW8dfw9NTbVbFbzhH5p5bWoqheaIDPkEo9RzvBYw0Hn31L7ACLs1iLq74HP9Dfhx37SXdWt7RK38stb-zS_zNg-XiZrms0_hURH8-nkYFkGO1rXhx_VX-pwZgs_vun_ATot3J28nwfpYhsAKGXcBaCUrI7XVTgtrM7zrUkRdEQVvFqrKgXEIJBM0plYoAyBVDMkY4igxFmTykO00bQOPGc_GxiFgjAGjHiF0pbWig-_R5kVVZTWM2KsrIZXLgX2jxKiFBFp6gZYk0NILdMQOSYrX7Yg3299AbSrX2lT-S5tG7MWVDpS4zih5ohtoL1bUETr7TCjs6NGgE9ddxWMxzpJMjVi2pS1bY9l-0tRzz-WdImAScfTkfwz-KbtN00E15VH6jO105xewh5CpM8_96vgNwHsXGg priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3bjtMwELXQ8sIL4k6Xi4yEVkJaU5I4iYOEUBYRyqWrit1K-xY5zmRrQZPSZhfyM3wIH8E3MZNktxT1BSkvcZw4zsx4zsTjY8aehioPAulkQhWFIlJtNCkXXKEV8St52guA_neMD4PRVH448U_Wy6P7D7jaGtrRflLT5dfnP741r9HgX1HEif52WCxmmqg9HUqLdIjQ9KorPUn6Pu7Bfjsuky9u-aQcdLMiQtfWzVtufciGn2rp_Ldh0H9TKf_yTckNdr0HlTzutOAmuwLlLbY36Vipm31-vF5ktdrne3yy5qtubrOfcVlbgX1H5Zi3k-58DLQg2K7mvCr4Oygt5Xbl8JK_L2c2s5QqzRE58hFGsUs85tDRfTdUP8EIvMoQldfik_0C_Kgpq3NbmQZRLT-3ur3z86yKhwtPjePJx-FhIn7_OhgmIsbRt-RH9pS6M0Fw-l03d9g0eXv8ZiT6bRuEkYFbC9AqyLNAG11oaUyIpYWPqMyh4M5AnheQFQg0PRxsjVQZQKBc8CJwHS8zEHh32U5ZlXCf8TDKCgSULmBUJKXOtVYYPSOC8pw8NxoG7NmFkNJFx86RYlRDAk1bgaYk0LQV6IAdkBQv6xGvdltQLU_T3kxTn8hogsx9YUBJRFrKKXKaGAYV5vgoM2BPLnQgRTukyRVdQnW2ooYQDIRSYUP3Op24bMqNZBR6oRqwcENbNt5l80ppZy3Xt4-ASrrO7n909AG7RieUWu74D9lOvTyDR4ic6uxxaxB_AHpLGXw priority: 102 providerName: Scholars Portal |
Title | Anti-inflammatory Mechanism of Geniposide: Inhibiting the Hyperpermeability of Fibroblast-Like Synoviocytes via the RhoA/p38MAPK/NF-κB/F-Actin Signal Pathway |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29497378 https://search.proquest.com/docview/2010367485 https://pubmed.ncbi.nlm.nih.gov/PMC5818421 https://doaj.org/article/512366b20ce8455481fd5657e87d201c |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLa2XXGDGL-FMRkJTUJaFpI4jstdN1HKT6eKbdLuIsc5WS2oU7XdUF6GB-EheCbOcdqtRVwhRblInDjJ-ezznfj4M2OvM1VKKaIiUFWlSFQbm1QMcaAV6SslOpFA_zuGp3JwIT5dppdbLF3NhfFJ-6awR-775MjZsc-tnE5MuMoTC0fDkxS9jIijcJttZ0myFqL77pdcrhTtkCQGYN2wmo41SX9GlDaJfIIEgLuimyW0ttqaN_Ki_f9imn8nTK55oP4Ddn9JHXmvfcRdtgXuITsYtdrTzSE_v5tKNT_kB3x0p0rdPGI_e25hA8QTQmDih9b5EGjar51PeF3xD-AsZXCV8I5_dGNbWEqI5sgP-QBj1RluE2hFvRsq38c4uy6Qey-CL_Yb8LPG1Te2Ng1yV35jtb_y67juhdNEDXujz-FpP_j96zjsBz3sYx0_s1f0OiOkoD9085hd9N-fnwyC5eIMgREyXgSglSwLqY2utDAmw6NVitwrohDOQFlWUFRIJxPsUo1QBYBUMSRdiKOkMCCTJ2zH1Q6eMZ51iwppYwwY-wihS60VxsjIk5KoLI2GDnuzMlI-bTU4coxdyLa5t21Ots29bTvsmKx4W47Us_2BenaVLzGUpyQ5I4v4rQElkE-pqCpp-BdUVuKtTIe9WmEgx9ZGQyjaQX09p4rQ5WdCYUVPW0zcVrXCVIdlG2jZeJbNMwhwr-i9BPTz_77yBbtH34DSyaN0j-0sZtfwEtnSotj3fxlwPxRq37eUPyXoGs0 |
link.rule.ids | 230,315,733,786,790,870,891,2115,24346,27955,27956,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbpswGLW67mK72f9P9utJU6VJJQww4OwurZalaxJFazv1Dtnmo0FdIEpIJ_Ywe5A9xJ5p3wehTardbBJXGLANx_b58PExY29DGQeBcLQlk0SSqTY2KRdcS0nyV_KUFwD97xiOgv6J-Hzqn24xv1kLU4n2jU7b2bdpO0snlbZyNjV2oxOzx8N9H0cZ4Tr2DXYT26vrrwXpVQdMg24g6klJDME6djKbKDL_dEg4iYyCLIA7ohN6tLva2nhU2fb_jWtel0yujUG9u-xrU_paenLeXha6bX5cM3b85-rdY3dWrJR36-T7bAuyB2xnXNtal7v8-GqV1mKX7_DxleF1-ZD97GZFaiFUEV3TataeD4FWFKeLKc8T_gmylMRhMXzgB9kk1SlprTlST97HMHiOxxRqv_CSru9hCJ9rpPWFNUjPgR-VWX6R5qZEWswvUlXd-WWSd-2ZJ4fd8aE96lm_f-3ZPauL3XfGj9Izqs4Y2e13VT5iJ72Px_t9a7Xvg2VE4BYWKBnEOlBGJUoYE-LZxEda51B0aCCOE9AJMlUPe2sjpAYIpAteB1zH0wYC7zHbzvIMnjIednSCjNQFDKuEULFSEsNvpGCeE8dGQYu9a75-NKvtPSIMiwg0UQWaiEATVaBpsT2Cx-V1ZMxdncjnZ9Hq-0U-udkE2n1vQAqkatJJYppZBhnG-CjTYm8acEXYkGl2RmWQLxeUEbKJUEjM6EkNtsusGrC2WLgBw42ybKYguCqz8BWYnv33na_Zrf7xcBANDkaHz9lteh-kWnf8F2y7mC_hJZKyQr-qmuAf-XI68Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwGLVgSIib8Q_l10hoEtLSkMRNXO66QejYWkVskyZuItv5skZbk6pNh8LD8CA8BM_E9yXt1k5cTcqV48RxcmyfLz4-Zux9IBPfF462ZJpKMtXGJuWCaylJ_kqe8nyg_x2Dod8_Ft9OOicrW33Von2js3Z-Pm7n2ajWVk7Gxl7qxOxosNvBUUa4jj1JUvs2u4Nt1g1WAvW6E6aB1xfNxCSGYV07nYwUGYA6JJ5EVkE2wF3RDTzaYW1lTKqt-__HN6_LJlfGofA--7GsQSM_OWvPS902v66ZO96oig_Y5oKd8l6T5SG7BfkjthU19tbVNj-6Wq012-ZbPLoyvq4es9-9vMwshCyibFzP3vMB0MribDbmRcq_Qp6RSCyBT3wvH2U6I801RwrK-xgOT_EYQ-MbXlH-EEP5QiO9L62D7Az4YZUXF1lhKqTH_CJT9ZXfR0XPnnhy0Iv27WFo_f2zY4dWD7vxnB9mp1SdCFnuT1U9Ycfhl6PdvrXY_8EywndLC5T0E-0ro1IljAkwNe0gvXMoSjSQJCnoFBmrh722EVID-NIFrwuu42kDvveUbeRFDs8ZD7o6RWbqAoZXQqhEKYlhOFIxz0kSo6DFPiwREE8am48YwyMCTlwDJybgxDVwWmyHIHKZjwy664RiehovvmHcIVcbX7sfDUiBlE06aUIzzCCDBG9lWuzdEmAxNmiapVE5FPMZFYSsIhASC3rWAO6yqCVgWyxYg-Las6yfQYDVpuELQL248ZVv2d3ocxgf7A33X7J79DpIvO50XrGNcjqH18jNSv2mboX_AKCGPXE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-inflammatory+Mechanism+of+Geniposide%3A+Inhibiting+the+Hyperpermeability+of+Fibroblast-Like+Synoviocytes+via+the+RhoA%2Fp38MAPK%2FNF-%CE%BAB%2FF-Actin+Signal+Pathway&rft.jtitle=Frontiers+in+pharmacology&rft.au=Deng%2C+Ran&rft.au=Li%2C+Feng&rft.au=Wu%2C+Hong&rft.au=Wang%2C+Wen-yu&rft.date=2018-02-15&rft.issn=1663-9812&rft.eissn=1663-9812&rft.volume=9&rft_id=info:doi/10.3389%2Ffphar.2018.00105&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fphar_2018_00105 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |